OPTINOSE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.08 USD | +8.22% |
|
-4.42% | -16.28% |
| 05-20 | OptiNose, Inc. announced that it has received $4.68 million in funding | CI |
| 05-14 | Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024 |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 422.7 | 215.6 | 133.2 | 203.2 | 144.9 | 144.5 | - | - |
| Enterprise Value (EV) 1 | 422.7 | 215.6 | 133.2 | 203.2 | 144.9 | 144.5 | 144.5 | 144.5 |
| P/E ratio | -3.51 x | -2 x | -1.12 x | -2.13 x | -4.03 x | -4.19 x | -13.9 x | 11.6 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 12.2 x | 4.39 x | 1.78 x | 2.66 x | 2.04 x | 1.57 x | 1.07 x | 0.85 x |
| EV / Revenue | 12.2 x | 4.39 x | 1.78 x | 2.66 x | 2.04 x | 1.57 x | 1.07 x | 0.85 x |
| EV / EBITDA | -4.99 x | -2.51 x | -2.02 x | -3.67 x | -6.48 x | -26.7 x | 13.8 x | 5.05 x |
| EV / FCF | -4.47 x | -2.49 x | -1.73 x | - | - | 139 x | 6.01 x | 4.31 x |
| FCF Yield | -22.4% | -40.2% | -57.9% | - | - | 0.72% | 16.6% | 23.2% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 45,842 | 52,081 | 82,200 | 109,840 | 112,312 | 144,839 | - | - |
| Reference price 2 | 9.220 | 4.140 | 1.620 | 1.850 | 1.290 | 1.080 | 1.080 | 1.080 |
| Announcement Date | 05/03/20 | 03/03/21 | 08/03/22 | 07/03/23 | 07/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 34.63 | 49.12 | 74.65 | 76.28 | 70.99 | 92.25 | 135.3 | 169.6 |
| EBITDA 1 | -84.63 | -85.76 | -65.8 | -55.36 | -22.35 | -5.417 | 10.48 | 28.64 |
| EBIT 1 | -95.6 | -87.22 | -66.45 | -55.9 | -22.75 | -12.18 | 7.627 | 28.19 |
| Operating Margin | -276.06% | -177.57% | -89.01% | -73.28% | -32.05% | -13.2% | 5.64% | 16.62% |
| Earnings before Tax (EBT) 1 | -110.1 | -99.79 | -82.3 | -74.83 | -35.48 | -32.44 | -9.765 | 14.72 |
| Net income 1 | -110.1 | -99.79 | -82.3 | -74.83 | -35.48 | -32.44 | -9.765 | 13.7 |
| Net margin | -317.79% | -203.16% | -110.24% | -98.11% | -49.99% | -35.17% | -7.22% | 8.08% |
| EPS 2 | -2.630 | -2.070 | -1.450 | -0.8700 | -0.3200 | -0.2575 | -0.0775 | 0.0933 |
| Free Cash Flow 1 | -94.59 | -86.75 | -77.1 | - | - | 1.039 | 24.06 | 33.57 |
| FCF margin | -273.15% | -176.62% | -103.28% | - | - | 1.13% | 17.78% | 19.8% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | 229.62% | 117.21% |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | 245.07% |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 05/03/20 | 03/03/21 | 08/03/22 | 07/03/23 | 07/03/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 22.51 | 14.76 | 20.58 | 20.08 | 20.86 | 11.85 | 19.45 | 19.82 | 19.86 | 14.88 | 21.08 | 24.13 | 32.6 | 24.2 | 33.4 |
| EBITDA 1 | -11.5 | -19.28 | - | - | -8.224 | - | - | - | - | - | -2.104 | -0.632 | 3.435 | - | - |
| EBIT 1 | -11.67 | -21.4 | -15.34 | -10.8 | -8.356 | -14.37 | -4.172 | -1.694 | -2.512 | -8.075 | -5.436 | -2.56 | 3.539 | -2.9 | 1 |
| Operating Margin | -51.84% | -144.95% | -74.56% | -53.79% | -40.07% | -121.29% | -21.45% | -8.55% | -12.65% | -54.27% | -25.79% | -10.61% | 10.86% | -11.98% | 2.99% |
| Earnings before Tax (EBT) 1 | -15.62 | -25.33 | -19.4 | -14.95 | -15.15 | -18.85 | 2.626 | -9.294 | -9.967 | -14.07 | -10.21 | -7.319 | -1.241 | -7.7 | -3.8 |
| Net income 1 | -15.62 | -25.33 | -19.4 | -14.95 | -15.15 | -18.85 | 2.573 | -9.294 | -9.967 | -14.07 | -10.21 | -7.319 | -1.241 | -7.7 | -3.8 |
| Net margin | -69.41% | -171.63% | -94.24% | -74.48% | -72.64% | -159.1% | 13.23% | -46.88% | -50.17% | -94.54% | -48.41% | -30.33% | -3.81% | -31.82% | -11.38% |
| EPS 2 | -0.2300 | -0.3100 | -0.2300 | -0.1800 | -0.1700 | -0.1700 | 0.0200 | -0.0800 | -0.0900 | -0.1200 | -0.0775 | -0.0575 | -0.0100 | -0.0500 | -0.0300 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 08/03/22 | 12/05/22 | 11/08/22 | 10/11/22 | 07/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 07/03/24 | 14/05/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt | - | - | - | - | - | - | - | - |
| Net Cash position | - | - | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | -94.6 | -86.8 | -77.1 | - | - | 1.04 | 24.1 | 33.6 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | 0.56 | 0.55 | 0.17 | 0.06 | 0.33 | 0.41 | 0.41 | 0.41 |
| Capex / Sales | 1.61% | 1.11% | 0.22% | 0.08% | 0.46% | 0.45% | 0.31% | 0.24% |
| Announcement Date | 05/03/20 | 03/03/21 | 08/03/22 | 07/03/23 | 07/03/24 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.08
USD
Average target price
3.75
USD
Spread / Average Target
+247.22%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.28% | 156M | |
| +55.95% | 819B | |
| +43.62% | 638B | |
| -6.98% | 351B | |
| +19.08% | 329B | |
| +9.05% | 298B | |
| +16.30% | 242B | |
| +2.41% | 225B | |
| +12.47% | 217B | |
| +8.91% | 168B |
- Stock Market
- Equities
- OPTN Stock
- Financials OptiNose, Inc.
